China Resources Pharmaceutical Group Ltd. (DE:640)
FRANKFURT:640
Holding DE:640?
Track your performance easily

China Resources Pharmaceutical Group Ltd. (640) Financial Statements

0 Followers

China Resources Pharmaceutical Group Ltd. Financial Overview

China Resources Pharmaceutical Group Ltd.'s market cap is currently ―. The company's EPS TTM is €0.079; its P/E ratio is 8.30; and it has a dividend yield of 4.63%. China Resources Pharmaceutical Group Ltd. is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsHK$ 60.23BHK$ 57.76BHK$ 52.21BHK$ 45.85BHK$ 43.36B
Total AssetsHK$ 256.26BHK$ 248.56BHK$ 234.00BHK$ 209.37BHK$ 197.17B
Total DebtHK$ 70.56BHK$ 56.55BHK$ 68.03BHK$ 44.16BHK$ 53.88B
Net DebtHK$ 10.33BHK$ -1.22BHK$ 15.83BHK$ -1.69BHK$ 10.52B
Total LiabilitiesHK$ 163.26BHK$ 153.58BHK$ 149.73BHK$ 129.34BHK$ 126.72B
Stockholders EquityHK$ 50.55BHK$ 50.98BHK$ 48.66BHK$ 46.47BHK$ 41.79B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in HKD

China Resources Pharmaceutical Group Ltd. Earnings and Revenue History

China Resources Pharmaceutical Group Ltd. Debt to Assets

China Resources Pharmaceutical Group Ltd. Cash Flow

China Resources Pharmaceutical Group Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis